These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Impact and Therapeutic Potential of PPARs in Alzheimer's Disease. Heneka MT; Reyes-Irisarri E; Hüll M; Kummer MP Curr Neuropharmacol; 2011 Dec; 9(4):643-50. PubMed ID: 22654722 [TBL] [Abstract][Full Text] [Related]
7. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810 [TBL] [Abstract][Full Text] [Related]
8. Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration. Durai P; Beeraka NM; Ramachandrappa HVP; Krishnan P; Gudur P; Raghavendra NM; Ravanappa PKB Curr Neuropharmacol; 2022; 20(5):893-915. PubMed ID: 34751120 [TBL] [Abstract][Full Text] [Related]
9. Mitochondria: a therapeutic target in neurodegeneration. Moreira PI; Zhu X; Wang X; Lee HG; Nunomura A; Petersen RB; Perry G; Smith MA Biochim Biophys Acta; 2010 Jan; 1802(1):212-20. PubMed ID: 19853657 [TBL] [Abstract][Full Text] [Related]
10. Glitazones Activate PGC-1α Signaling via PPAR-γ: A Promising Strategy for Antiparkinsonism Therapeutics. P P; Justin A; Ananda Kumar TD; Chinaswamy M; Kumar BRP ACS Chem Neurosci; 2021 Jul; 12(13):2261-2272. PubMed ID: 34125534 [TBL] [Abstract][Full Text] [Related]
11. Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy. Strosznajder AK; Wójtowicz S; Jeżyna MJ; Sun GY; Strosznajder JB Neuromolecular Med; 2021 Mar; 23(1):86-98. PubMed ID: 33210212 [TBL] [Abstract][Full Text] [Related]
13. PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation. Zolezzi JM; Santos MJ; Bastías-Candia S; Pinto C; Godoy JA; Inestrosa NC Biol Rev Camb Philos Soc; 2017 Nov; 92(4):2046-2069. PubMed ID: 28220655 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review. Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Wu Y; Chen M; Jiang J Mitochondrion; 2019 Nov; 49():35-45. PubMed ID: 31288090 [TBL] [Abstract][Full Text] [Related]
16. The Role of Mitophagy in Various Neurological Diseases as a Therapeutic Approach. Kaur S; Sharma N; Kumar V; Sharma D; Devi B; Kapil L; Singh C; Singh A Cell Mol Neurobiol; 2023 Jul; 43(5):1849-1865. PubMed ID: 36326951 [TBL] [Abstract][Full Text] [Related]
17. Insulin is a two-edged knife on the brain. Cardoso S; Correia S; Santos RX; Carvalho C; Santos MS; Oliveira CR; Perry G; Smith MA; Zhu X; Moreira PI J Alzheimers Dis; 2009; 18(3):483-507. PubMed ID: 19542630 [TBL] [Abstract][Full Text] [Related]
18. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders. Olesen MA; Villavicencio-Tejo F; Quintanilla RA Transl Neurodegener; 2022 Jul; 11(1):36. PubMed ID: 35787292 [TBL] [Abstract][Full Text] [Related]
19. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Chen Z; Zhong C Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509 [TBL] [Abstract][Full Text] [Related]
20. PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease. Corona JC; Duchen MR Free Radic Biol Med; 2016 Nov; 100():153-163. PubMed ID: 27352979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]